{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/meningitis-bacterial-meningitis-meningococcal-disease/background-information/prognosis/","result":{"pageContext":{"chapter":{"id":"6e9b6946-ed39-54a6-9e90-9989f22e636b","slug":"prognosis","fullItemName":"Prognosis","depth":2,"htmlHeader":"<!-- begin field 85eff935-c090-409d-801e-853177a95d5e --><h2>What is the prognosis of acute bacterial meningitis?</h2><!-- end field 85eff935-c090-409d-801e-853177a95d5e -->","summary":"","htmlStringContent":"<!-- begin item 60eed8d5-a548-410d-a317-a3649a21b776 --><!-- begin field 6a78c123-1140-4a02-8cca-8bf3c7d047e4 --><ul><li>With prompt and adequate antimicrobial treatment and supportive therapy, the outcome of acute bacterial meningitis is excellent. </li><li>Factors that affect the prognosis of bacterial meningitis include: <ul><li>Age — fatality rates are high among people at the extremes of age (neonates and older people). The case-fatality rates for bacterial meningitis are 4–10% in children and 25% in adults. <ul><li>Most deaths occur in the first 24–48 hours.</li></ul></li><li>The causative organism — in England in 2018/19, the case-fatality ratio for invasive meningococcal disease was 5%. <ul><li>Case-fatality rates are 3–7% for <em>Haemophilus influenzae</em> and <em>Streptococcus agalactia</em>, 20–25% for <em>Streptococcus pneumoniae</em>, and 30–40% for <em>Listeria monocytogenes</em>.</li></ul></li><li>Presence of comorbidities.</li><li>Severity at presentation.</li></ul></li><li>In children aged up to 18 years with bacterial meningitis, other significant prognostic factors include:<ul><li>Symptoms lasting more than 48 hours before admission.</li><li>Coma/impaired consciousness.</li><li>Prolonged seizures (more than 12 hours after admission).</li><li>Prolonged fever (more than 7 days).</li><li>Shock.</li><li>Peripheral circulatory failure.</li><li>Respiratory distress.</li><li>Absence of petechiae (petechiae occurs much less with <em>S. pneumoniae</em>).</li><li>Male gender.</li><li><em>S. pneumoniae</em> being the causative organism (case fatality rates are higher).</li></ul></li><li>Features associated with a poor prognosis in adults include: <br><ul><li>Low Glasgow Coma Scale score on admission (low level of consciousness).</li><li>Tachycardia. </li><li>Absence of rash.</li><li>Thrombocytopenia.</li><li>Elevated erythrocyte sedimentation rate (ESR). </li><li>Positive blood culture. </li><li>Cerebrospinal fluid leucocyte count of less than 1000 x 10<sup>9</sup> cells per mL.</li></ul></li><li><a class=\"topic-reference internal-reference\" href=\"/topics/meningitis-bacterial-meningitis-meningococcal-disease/background-information/complications/\">Complications</a> of bacterial meningitis occur in up to 30% of children and up to one-third of adults and are more common in pneumococcal meningitis than in meningococcal meningitis.</li></ul><p>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/meningitis-bacterial-meningitis-meningococcal-disease/references/\">de Jonge, 2010</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/meningitis-bacterial-meningitis-meningococcal-disease/references/\">McGill, 2016b</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/meningitis-bacterial-meningitis-meningococcal-disease/references/\">Olbrich, 2018</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/meningitis-bacterial-meningitis-meningococcal-disease/references/\">PHE, 2019b</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/meningitis-bacterial-meningitis-meningococcal-disease/references/\">BMJ, 2020</a>]</p><!-- end field 6a78c123-1140-4a02-8cca-8bf3c7d047e4 --><!-- end item 60eed8d5-a548-410d-a317-a3649a21b776 -->","topic":{"id":"5c52d7ca-c2cb-5551-ba9f-1fcdbdf1faad","topicId":"b3676823-9bef-422c-a1fe-011ca9f6883f","topicName":"Meningitis - bacterial meningitis and meningococcal disease","slug":"meningitis-bacterial-meningitis-meningococcal-disease","lastRevised":"Last revised in July 2020","chapters":[{"id":"12319bd7-3980-5b0c-8deb-b4351ef52f99","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"c72ab6e0-adbe-5cb4-9d67-4909820fb847","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"f9d67392-74e7-5adf-b712-fa42f7e69711","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"af144a12-5e1e-5d97-8d14-45db380ecef0","slug":"changes","fullItemName":"Changes"},{"id":"eb9e7802-cda3-5c04-b178-4ae4c2bb0003","slug":"update","fullItemName":"Update"}]},{"id":"9719c30a-3d48-51f7-8a76-d9a376cfc395","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"34af18fa-646e-5799-8eea-3070c9be3955","slug":"goals","fullItemName":"Goals"},{"id":"d1170912-4321-588d-88ca-217aea38c5c4","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"777fba00-f0b7-56ca-aad8-482a8107aa53","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"6162c8c1-72d4-5418-b083-e9261dc043af","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"8b16062f-23c7-57ef-9c04-d8696d43c468","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"141459fa-eb5f-51e0-a4f1-55aa8fcf568a","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"45808ab8-48c2-500e-904e-b28b1dd9f2c1","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"a71886c1-a30d-566c-84b9-d1fd02dbacd0","slug":"definition","fullItemName":"Definition"},{"id":"3bf2ba08-2574-58c3-9147-499dd2671f06","slug":"causes","fullItemName":"Causes"},{"id":"9d242c7b-d3c1-5081-8db2-1d366c43c71d","slug":"transmission","fullItemName":"Transmission"},{"id":"46f40806-a5d8-5742-ad5b-35abf21b89bb","slug":"prevalence","fullItemName":"Prevalence"},{"id":"20fadd0c-adea-5cb2-8cb7-cc9df62dd094","slug":"risk-factors","fullItemName":"Risk factors"},{"id":"6f81c33d-8bac-5747-bd44-5b3244f57b58","slug":"complications","fullItemName":"Complications"},{"id":"6e9b6946-ed39-54a6-9e90-9989f22e636b","slug":"prognosis","fullItemName":"Prognosis"}]},{"id":"5bcb31df-47de-5f61-bdb9-90d4ff02c6c4","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"eeb07a78-3dda-516a-943d-8418d5224628","slug":"when-to-suspect","fullItemName":"When to suspect"},{"id":"5644216d-a652-51b5-a696-c9e4aac4b609","slug":"assessing-the-rash","fullItemName":"Assessing the rash"},{"id":"2fb8dc81-2176-50e5-a2c5-1bb1541cddfc","slug":"assessing-vital-signs","fullItemName":"Assessing vital signs"},{"id":"0f916e0f-ed47-5988-843a-19af47c3726d","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"75dbccb7-b3c5-51dc-8069-f497798fd646","fullItemName":"Management","slug":"management","subChapters":[{"id":"1b657d07-eb89-5d3b-9404-ef623a716920","slug":"non-blanching-rash-or-meningococcal-septicaemia","fullItemName":"Scenario: Non-blanching rash or meningococcal septicaemia"},{"id":"414935f6-7030-5ea4-a397-cac8958da2c7","slug":"without-non-blanching-rash","fullItemName":"Scenario: Without non-blanching rash"},{"id":"d532e29d-6fc3-54b3-b286-b1e80ce7840c","slug":"managing-close-contacts","fullItemName":"Scenario: Managing close contacts"},{"id":"81e1e9d4-a4c9-5c10-80d9-07cc83d6dba2","slug":"follow-up-after-hospital-discharge","fullItemName":"Scenario: Follow up after hospital discharge"}]},{"id":"c620569e-fa7a-5c2c-a708-ec6432bf5c51","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"9f59f8a5-e555-56ba-861a-a492cfe5a298","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"9c42a3ff-6a45-5e6c-a247-51a81848f67a","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"50077a62-1fb9-5968-a1e6-71ac64bcf7e1","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"7e85d7bc-8751-5e8f-8e77-8b91b0cf1141","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"7fb74eaa-420c-5cdd-a04e-92cbd9be478c","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"b8d54b7e-8c9b-5d53-8a0a-6a7296727eb4","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"71898679-d838-5f6d-8422-64c378e43045","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"45808ab8-48c2-500e-904e-b28b1dd9f2c1","slug":"background-information","fullItemName":"Background information"},"subChapters":[]}}},"staticQueryHashes":["3666801979"]}